ArticleJMIR medical informatics2020
A Smartphone App to Manage Cirrhotic Ascites Among Outpatients: Feasibility Study.
Article in JMIR medical informatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 37 citations in OpenAlex.
- Feasibility and acceptability of pharmacist-led remote patient monitoring for carvedilol dose titration in clinically significant portal hypertension.International journal of clinical pharmacy · 2026Article
- Clinical and Demographic Determinants of Adherence to Digital Monitoring in Cirrhosis: A Prospective Cohort Analysis.Research square · 2026Article
- Quality of Evidence in Remote Monitoring of Patients With Liver Cirrhosis: A Systematic Review.Gastro hep advances · 2026Review
- Optimization of outpatient care for patients with decompensated liver cirrhosis: a post-discharge nursing initiative improves quality of life.Hepatobiliary surgery and nutrition · 2025Article
- eHealth Self-Management Interventions for Patients With Liver Cirrhosis: Scoping Review.Journal of medical Internet research · 2025Article
- Current Situation and Prospects of Digital Therapeutics in the Field of Liver Diseases in China.Advances in therapy · 2025Review
- Telemedicine in the tertiary liver unit: A feasibility study.Clinical and experimental hepatology · 2024Article
- Design, implementation, and impact of a cirrhosis-specific remote patient monitoring program.Hepatology communications · 2024Article
- The rise of mobile apps for the management of chronic liver disease.Hepatology communications · 2024Article
- Fabry App: the value of a portable technology in recording day-to-day patient monitored information in patients with Fabry disease.Orphanet journal of rare diseases · 2024Article
- Patient Portal Use and Risk of Readmissions in Decompensated Cirrhosis: Retrospective Study.JMIR formative research · 2023Article
- Integrating smart phone applications in the management of cirrhotic patients: A scoping review.JGH open : an open access journal of gastroenterology and hepatology · 2023Article
- Telemedicine in Patients Affected by Chronic Liver Disease: A Scoping Review of Clinical Outcomes and the Devices Evaluated.Journal of clinical medicine · 2023Article
- Confronting Disparities in Telehepatology Research.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2023Article
- Low haemoglobin level predicts early hospital readmission in patients with cirrhosis and acute decompensation.JHEP reports : innovation in hepatology · 2023Article
- Leveraging Telemedicine for Quality Assessment.Clinical liver disease · 2022Review
- Monitoring for Ascites in Cirrhosis Using Patient-Generated Health Data: No Longer a Remote Possibility.Digestive diseases and sciences · 2022Article
- The digital transformation of hepatology: The patient is logged in.Hepatology (Baltimore, Md.) · 2022Review
- Strategies to Improve Delivery of Cirrhosis Care.Current treatment options in gastroenterology · 2021Review
- How to improve preventive health care in patients with cirrhosis.Clinical liver diseaseReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAscites is a common, painful, and serious complication of cirrhosis. Body weight is a reliable proxy for ascites volume; therefore, daily weight monitoring is recommended to optimize ascites management.
objectiveThis study aims to evaluate the feasibility of a smartphone app in facilitating outpatient ascites management.
methodsIn this feasibility study, patients with cirrhotic ascites requiring active management were identified in both inpatient and outpatient settings. Patients were provided with a Bluetooth-connected scale, which transmitted weight data to a smartphone app and then via the internet to an electronic medical record (EMR). Weights were monitored every weekday. In the event of a weight change of ≥5 lbs in 1 week, patients were called and administered a short symptom questionnaire, and providers received an email alert. The primary outcomes of this study were the percentage of enrolled days during which weight data were successfully transmitted to an EMR and the percentage of weight alerts that prompted responses by the provider.
resultsIn this study, 25 patients were enrolled: 12 (48%) were male, and the mean age was 58 (SD 13; range 35-81) years. A total of 18 (72%) inpatients were enrolled. Weight data were successfully transmitted to an EMR during 71.2% (697/979) of the study enrollment days, with technology issues reported on 16.5% (162/979) of the days. Of a total of 79 weight change alerts fired, 41 (52%) were triggered by weight loss and 38 (48%) were by weight gain. Providers responded in some fashion to 66 (84%) of the weight alerts and intervened in response to 45 (57%) of the alerts, for example, by contacting the patient, scheduling clinic or paracentesis appointments, modifying the diuretic dose, or requesting a laboratory workup. Providers responded equally to weight increase and decrease alerts (P=.87). The staff called patients a mean of 3.7 (SD 3.5) times per patient, and the number of phone calls correlated with technology issues (r=0.60; P=.002). A total of 60% (15/25) of the patients chose to extend their participation beyond 30 days. A total of 17 patient readmissions occurred during the study period, with only 4 (24%) related to ascites.
conclusionsWe demonstrated the feasibility of a smartphone app to facilitate the management of ascites and reported excellent rates of patient and provider engagement. This innovation could enable early therapeutic intervention, thereby decreasing the burden of morbidity and mortality among patients with cirrhosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.